In a study involving bone marrow samples from 117 newly diagnosed pediatric BCP-ALL patients, high CRLF2 expression was found to be associated with significantly worse event-free survival (EFS) as compared to patients with low CRLF2 expression [63]. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.